Research Article
Catastrophic Outcomes in Free Tissue Transfer: A Six-Year Review of the NSQIP Database
Table 3
Population demographics, stratified by catastrophic outcome.
| | Catastrophic outcome | No catastrophic outcome | | value | | = 122 | = 2,227 | | | | % | | % | |
| Age (years, mean ± SD) | 61.0 ± 14.3 | | 53.9 ± 12.7 | | | 0.000 | BMI (kg/m2, mean ± SD) | 26.4 ± 6.5 | | 27.9 ± 6.3 | | | 0.007 | Sex | | | | | | | Male | 73 | 59.8% | 598 | 26.9% | | 0.000 | Female | 49 | 40.2% | 1629 | 73.1% | | | Race (%) | | | | | | | White | 93 | 76.2% | 1639 | 73.6% | | | Black | 6 | 4.9% | 238 | 10.7% | | | Asian | 1 | 0.8% | 60 | 2.7% | | | Other | 22 | 18.0% | 290 | 13.0% | | | Clinical characteristics | | | | | | | Active smoker within one year | 35 | 28.7% | 371 | 16.7% | | 0.001 | EtOH > 2 drinks/day in preceding 2 wks | 8 | 6.6% | 68 | 3.1% | | 0.057 | Steroid use | 5 | 4.1% | 33 | 1.5% | | 0.044 | Radiotherapy <90 days | 7 | 5.7% | 29 | 1.3% | | 0.002 | Chemotherapy <30 days | 4 | 3.3% | 90 | 4.0% | | 1.000 | Previous OP <30 days | 12 | 9.8% | 109 | 4.9% | | 0.016 | Comorbidities | | | | | | | Diabetes | 24 | 19.7% | 180 | 8.1% | | 0.000 | Hypertension | 66 | 54.1% | 739 | 33.2% | | 0.000 | Dyspnea | 17 | 13.9% | 115 | 5.2% | | 0.000 | Bleeding disorder | 12 | 9.8% | 39 | 1.8% | | 0.000 | Ventilator dependent status preop | 3 | 2.5% | 3 | 0.1% | | 0.002 | History of severe COPD | 7 | 5.7% | 59 | 2.6% | | 0.080 | Systemic sepsis | 8 | 6.6% | 42 | 1.9% | | 0.004 | Open wound infection | 26 | 21.3% | 209 | 9.4% | | 0.000 | Disseminated cancer | 11 | 9.0% | 77 | 3.5% | | 0.005 | History of cardiac surgery | 7 | 5.7% | 32 | 1.4% | | 0.003 | Peripheral vascular disease | 2 | 1.6% | 23 | 1.0% | | 0.376 | Cerebrovascular disease | 13 | 10.7% | 53 | 2.4% | | 0.000 |
|
|
denotes significant value, < 0.05. Fisher’s Exact Test; all others Pearson chi-square. BMI = body mass index; EtOH = alcohol consumption; OP = operation; COPD = chronic obstructive pulmonary disease.
|